PCI The Journeys Within
CPHI 2026 – 23/07/2026

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Sharp’s Emissions Reduction Targets Validated by Science Based Targets initiative

Sharp, a leader in pharmaceutical packaging, clinical trial supply services and small-scale sterile manufacturing announced today that its near-term and long-term gr...
Continue Reading →
Regional News

Building A Faster, More Effective Clinical Trials System

As I celebrate my first International Clinical Trials Day at the MHRA, I’ve been reflecting on the incredible work underway here to make it faster and easier to run ...
Continue Reading →
Regional News

China Bans Popular Alzheimer’s Disease Surgery Pending Clinical Studies

National Health Commission says more research needed on procedure that has been performed in nearly 400 hospitals across the country Beijing has banned a surgical...
Continue Reading →
Regional News

Clinical Trials Reveal Promising Alternatives to High-Toxicity Tuberculosis Drug

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with the potential to...
Continue Reading →
Regional News

Unprecedented boost for clinical trials under 10 Year Health Plan

Millions will take part in clinical trials under the 10 Year Health Plan, which will speed up clinical research. Millions to take part in clinical trials under 1...
Continue Reading →
Regional News

Call to Improve Inclusivity in Clinical Research

Fewer people from ethnic minority backgrounds were willing to participate in clinical trials  In most clinical trials, the participation of ethnic minority adults...
Continue Reading →
Regional News

Eli Lilly Seeks Green Light for Weekly Insulin After Strong Trial Results

While still an injectable, once-weekly dosing offers a simpler treatment regimen for patients. Eli Lilly is looking to approach regulators for approval of its onc...
Continue Reading →
news

Merck’s Leader in Oral PCSK9 Inhibitor Race Reduces Cholesterol in Pair of Phase 3 Trials

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma unveiled a pair of phase 3 wins for enlici...
Continue Reading →
news

Navigating Clinical Trials: A Guide for Patients Seeking Experimental Treatments

For many patients grappling with serious health conditions like ALS (Amyotrophic Lateral Sclerosis), the search for effective treatments can feel like an uphill batt...
Continue Reading →
news

EU: Trials Should Include Pregnant Subjects where Possible

New guidance from the EMA has introduced a shift in thinking at the regulator on the inclusion of pregnant and breastfeeding women in clinical trials. The new doc...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026